First COVID jab provides protection for most myeloma blood cancer patients
A single dose of a COVID-19 vaccine triggers an immune response in around 70% of patients with myelo...
Researchers identify potential targets for novel treatments for lung cancer
Lung cancer is the most common cause of cancer dea...
They tested negative for COVID. Still, they have long COVID symptoms
Kristin Novotny once led an active life, with regu...
FDA's call to pause Johnson & Johnson COVID-19 vaccine 'strong argument for safety,' Fauci says
Feds recommend pause in Johnson & Johnson ...
The best hope for fairly distributing COVID-19 vaccines globally is at risk—but there’s a chance to fix that
COVAX, the global initiative to coordinate the dis...
National Minority Health Month: Fighting for health equity year ’round
April is National Minority Health Month, making it...
Excellent outcomes reported for first targeted therapy for pediatric Hodgkin lymphoma
Scientists are reporting results of the first fron...
‘Double mutant’ coronavirus variant detected in US for first time
A “double mutant” variant of the coron...
Moderna COVID vaccine offers protection for at least 6 months, study finds
(HealthDay)—There’s good news for the mill...
